drugset / Trial / NCT00772889
Evaluation of the Safety and Immunogenicity of the Influenza Vaccine GSK2186877A in the Elderly
Non-randomizedParallel-groupTriple-blindPrevention
Summary
The purpose of this observer-blind clinical trial is to evaluate the safety and immunogenicity of GlaxoSmithKline Biologicals' influenza vaccine GSK2186877A in the elderly. Subjects were previously vaccinated (NCT00529516).
Timeline
- Start
- 2008-10-09
- Primary completion
- 2009-12-15
- Completion
- 2009-12-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | GSK2186877A | Vaccine | — | Intramuscular |
| Comparator | Influenza Virus Vaccine | Vaccine | — | Intramuscular |